TrialHaematologica2026

Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial.

Adriana Balduzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.